back to top

FDA Raises Concerns About Cell Therapeutics' Cancer Drug

Drug reviewers working for the Food and Drug Administration raised concerns about the efficacy and safety of Cell Therapeutics'(CTIC Quote) lymphoma drug pixantrone drug, according to a review of the drug posted to the agency's Web site Monday.

Posted on